# The essential role of miR-27a in craniofacial and body skeletons.

> **NIH NIH R21** · UNIVERSITY OF ROCHESTER · 2020 · $161,178

## Abstract

Title
The essential role of miR-27a in craniofacial and body skeletons
Abstract
MicroRNAs are ~22 nucleotides noncoding RNAs which control gene expression at post-transcriptional levels.
Owing to its ability to simultaneously modulate a vast amount of genes, microRNA has been postulated to work
as a master regulator for cell type-specific development and function. Although gain-of-function analysis with
microRNA overexpression can affect these processes in transgenic mice, loss-of-function study often fails to
detect phenotypic alterations and is unable to faithfully determine their role in development and disease.
Moreover, results obtained from in vitro analysis sometimes are not supported by functional analyses in vivo.
Studies of Dicer, an enzyme essential for biosynthesis of microRNAs, have implicated their importance in bone
remodeling. However, the exact miRNA(s) involved has not been identified. The cluster of miR-23a~27a~24-2
consists of three miRNAs generated from a single transcript. Dysregulation of miR-23a and miR-27a has been
shown in osteoporosis patients but their regulatory role remains elusive. In cell culture study, high levels of
miR-23a or miR-27a inhibits OB differentiation, suggesting that they are negative regulators for bone formation.
In mice, OB-specific expression of miR-23a~27a~24-2 cluster reveals its effects on osteocyte but not OB
differentiation. The animal study does not support the cell culture analysis. There is an urgent need to develop
loss-of-function models to definitively assess the function of these microRNAs in vivo. To fill our knowledge
gaps, we created a mouse model deficient for miR-27a using CRSPR-Cas9 gene editing. The loss of this
single miRNA causes severe osteoporosis in the craniofacial and body skeletons, suggesting the function of
miR-27a cannot be substituted. The bone loss phenotype also becomes more prominent with age. New
genetic evidence, indicating miR-27a as a positive regulator in bone remodeling, strongly argues against the
previous cell culture study. In this application, we will characterize craniofacial and skeletal defects in miR-27a
deficient mice. We will examine osteoblast and osteoclast abnormalities associated with the mutation to cause
an imbalance in skeletal remodeling. To further elucidate the mechanism by which miR-27a regulates bone
formation and resorption, we will identify its direct targets using unbiased screening. The completion of this
proposal has outstanding potential to advance our knowledge base of epigenetic regulation in bone
metabolism, leading to novel strategies for prevention and treatment of craniofacial and skeletal disorders.

## Key facts

- **NIH application ID:** 9900768
- **Project number:** 5R21DE028696-02
- **Recipient organization:** UNIVERSITY OF ROCHESTER
- **Principal Investigator:** Takamitsu Maruyama
- **Activity code:** R21 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $161,178
- **Award type:** 5
- **Project period:** 2019-04-01 → 2021-05-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/9900768

## Citation

> US National Institutes of Health, RePORTER application 9900768, The essential role of miR-27a in craniofacial and body skeletons. (5R21DE028696-02). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/9900768. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*